Zhejiang Jingxin Pharmaceutical Co Ltd
002020
Company Profile
Business description
Zhejiang Jingxin Pharmaceutical Co Ltd is an integrated pharmaceuticals enterprise that focuses on manufacturing, R&D, and marketing. It offers finished dosage forms which include tablets, capsules, and injections in the areas of antilipemic, antidiabetic, cholesterolemia, luoroquinolones, cephalosporin, gastrointestinal promotion, anti-inflammatory analgesic, and antibiotics; APIs, and Chinese herbal drugs. The products are sold to overseas markets such as South-east of Asia, South Asia, Latin America and Europe.
Contact
No.800 Xinchang East Road
Yulin subdistrict
Zhejiang Province
Xinchang312500
CHNT: +86 57586298518
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
3,869
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,554.00 | 293.60 | -3.74% |
| CAC 40 | 7,274.95 | 324.03 | -4.26% |
| DAX 40 | 20,641.72 | 1,075.67 | -4.95% |
| Dow JONES (US) | 38,314.86 | 2,231.07 | -5.50% |
| FTSE 100 | 8,054.98 | 419.76 | -4.95% |
| HKSE | 20,677.74 | 2,172.07 | -9.51% |
| NASDAQ | 15,587.79 | 962.82 | -5.82% |
| Nikkei 225 | 31,591.84 | 2,188.74 | -6.48% |
| NZX 50 Index | 11,870.31 | 354.97 | -2.90% |
| S&P 500 | 5,074.08 | 322.44 | -5.97% |
| S&P/ASX 200 | 7,378.80 | 289.00 | -3.77% |
| SSE Composite Index | 3,147.59 | 194.42 | -5.82% |